<Summary id="CDR0000597824" LegacyPDQID=""><SummaryMetaData><SummaryType>Treatment</SummaryType><SummaryAudience>Patients</SummaryAudience><SummaryLanguage>English</SummaryLanguage><SummaryDescription>Langerhans Cell Histiocytosis (LCH) treatment depends on where it is found in the body and whether the LCH is low or high risk. Treatment can include chemotherapy, surgery, radiation therapy, photodynamic therapy, immunotherapy, and targeted therapy. Learn more in this expert-reviewed summary.</SummaryDescription><SummaryURL xref="https://www.cancer.gov/types/langerhans/patient/langerhans-treatment-pdq">Langerhans Cell Histiocytosis (PDQ®): Treatment</SummaryURL><SummaryToggleURL xref="https://www.cancer.gov/types/langerhans/hp/langerhans-treatment-pdq">Langerhans Cell Histiocytosis (PDQ®): Treatment</SummaryToggleURL><SummaryEditorialBoard ref="CDR0000028557">PDQ Pediatric Treatment Editorial Board</SummaryEditorialBoard><MainTopics><TermRef ref="CDR0000039054">childhood Langerhans cell histiocytosis</TermRef></MainTopics><MainTopics><TermRef ref="CDR0000641605">adult Langerhans cell histiocytosis</TermRef></MainTopics><SummaryAbstract><Para id="_463">This PDQ cancer information summary has current information about the treatment of childhood and adult Langerhans cell histiocytosis. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para><Para id="_464">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change. The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Pediatric Treatment Editorial Board.</Para></SummaryAbstract><SummaryKeyWords><SummaryKeyWord>Adult Langerhans cell histiocytosis</SummaryKeyWord><SummaryKeyWord>childhood Langerhans cell histiocytosis</SummaryKeyWord></SummaryKeyWords></SummaryMetaData><SummaryTitle>Langerhans Cell Histiocytosis Treatment (PDQ®)–Patient Version</SummaryTitle><AltTitle TitleType="Browser">Langerhans Cell Histiocytosis Treatment</AltTitle><AltTitle TitleType="CancerTypeHomePage">Langerhans Cell Histiocytosis Treatment</AltTitle><SummarySection id="_1"><Title>General Information About Langerhans Cell Histiocytosis (LCH)</Title><SummarySection id="_2"><SectMetaData><SectionType>Cancer description</SectionType><SectionType>Organ description</SectionType></SectMetaData><KeyPoint id="_3">Langerhans cell histiocytosis is a rare disorder that can damage tissue or cause lesions to form in one or more places in the body.</KeyPoint><Para id="_459"><GlossaryTermRef href="CDR0000471787" dictionary="Cancer.gov" audience="Patient">Langerhans cell histiocytosis</GlossaryTermRef> (LCH) is a rare disease that begins in  LCH <GlossaryTermRef href="CDR0000046476" dictionary="Cancer.gov" audience="Patient">cells</GlossaryTermRef>. LCH cells are a type of <GlossaryTermRef href="CDR0000044948" dictionary="Cancer.gov" audience="Patient">dendritic cell</GlossaryTermRef> that normally helps the body fight <GlossaryTermRef href="CDR0000045364" dictionary="Cancer.gov" audience="Patient">infection</GlossaryTermRef>. Sometimes <GlossaryTermRef href="CDR0000046063" dictionary="Cancer.gov" audience="Patient">mutations</GlossaryTermRef> (changes)  develop in <GlossaryTermRef href="CDR0000045693" dictionary="Cancer.gov" audience="Patient">genes</GlossaryTermRef> that control how dendritic cells function. These include  mutations  of the <GeneName><GlossaryTermRef href="CDR0000561325" dictionary="Cancer.gov" audience="Patient">BRAF</GlossaryTermRef></GeneName>, <GeneName>MAP2K1</GeneName>, <GeneName><GlossaryTermRef href="CDR0000045859" dictionary="Cancer.gov" audience="Patient">RAS</GlossaryTermRef></GeneName>, and <GeneName>ARAF</GeneName> genes. These mutations may cause too many LCH cells to grow and build up in certain parts of the body, where they can damage  <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef> or form <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef>. </Para><SummarySection id="_4808"><KeyPoint id="_4809">It is not known whether LCH is a form of cancer or a cancer-like disease.</KeyPoint><Para id="_4810">Doctors who treat <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> also treat LCH, and sometimes they use cancer <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapies</GlossaryTermRef> to treat this disease. For more information, see the sections on the <SummaryRef href="CDR0000597824#_318" url="/types/langerhans/patient/langerhans-treatment-pdq">treatment of LCH in children</SummaryRef> and the <SummaryRef href="CDR0000597824#_236" url="/types/langerhans/patient/langerhans-treatment-pdq">treatment of LCH in adults</SummaryRef>.</Para></SummarySection></SummarySection><SummarySection id="_6"><SectMetaData><SectionType>Risk factors</SectionType></SectMetaData><KeyPoint id="_7">Family history of cancer or having a parent who was exposed to certain chemicals may increase the risk of LCH.</KeyPoint><Para id="_8">Anything that increases a person's risk of getting a disease is called a <GlossaryTermRef href="CDR0000045873" dictionary="Cancer.gov" audience="Patient">risk factor</GlossaryTermRef>.  Not every child with one or more of these risk factors will develop LCH, and it will develop in some children who don’t have any known risk factors. Talk with your doctor if you think you may be at risk.</Para><Para id="_472"> Risk factors for  LCH may include the following:</Para><ItemizedList id="_9" Style="bullet"> 
    <ListItem>Having a parent who was exposed to certain <GlossaryTermRef href="CDR0000463162" dictionary="Cancer.gov" audience="Patient">solvents</GlossaryTermRef>.</ListItem> 
    <ListItem>Having a parent who was exposed to metal, granite, or wood dust in the workplace.</ListItem><ListItem>Having a <GlossaryTermRef href="CDR0000302456" dictionary="Cancer.gov" audience="Patient">family history</GlossaryTermRef> of cancer or LCH.</ListItem> 
    <ListItem>Having a    <GlossaryTermRef href="CDR0000642021" dictionary="Cancer.gov" audience="Patient">personal history</GlossaryTermRef> or family history of <GlossaryTermRef href="CDR0000046036" dictionary="Cancer.gov" audience="Patient">thyroid</GlossaryTermRef> disease.</ListItem> 
     
   <ListItem> Having  infections as a newborn.</ListItem><ListItem>Smoking, especially in young adults.</ListItem><ListItem>Being Hispanic.</ListItem><ListItem>Not being <GlossaryTermRef href="CDR0000044841" dictionary="Cancer.gov" audience="Patient">vaccinated</GlossaryTermRef> as a child.</ListItem></ItemizedList></SummarySection><SummarySection id="_289"><SectMetaData><SectionType>Symptoms</SectionType></SectMetaData><KeyPoint id="_290">The signs and symptoms of LCH depend on where it is in the body.</KeyPoint><Para id="_15">These and other <GlossaryTermRef href="CDR0000750109" dictionary="Cancer.gov" audience="Patient">signs</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> may be caused by LCH or by other <GlossaryTermRef href="CDR0000651193" dictionary="Cancer.gov" audience="Patient">conditions</GlossaryTermRef>. Check with your doctor if you or your child have any of the following:</Para><SummarySection id="_188"><KeyPoint id="_189">Bone</KeyPoint><Para id="_326">Signs or symptoms of LCH that affects the bone may include:</Para><ItemizedList id="_327" Style="bullet"><ListItem>Swelling or a lump over a bone, such as the <GlossaryTermRef href="CDR0000763008" dictionary="Cancer.gov" audience="Patient">skull</GlossaryTermRef>, jawbone,  ribs, <GlossaryTermRef href="CDR0000046246" dictionary="Cancer.gov" audience="Patient">pelvis</GlossaryTermRef>, <GlossaryTermRef href="CDR0000415914" dictionary="Cancer.gov" audience="Patient">spine</GlossaryTermRef>, thigh bone, upper arm bone,  elbow, <GlossaryTermRef href="CDR0000797677" dictionary="Cancer.gov" audience="Patient">eye socket</GlossaryTermRef>, or bones around the ear.<GlossaryTermRef href="CDR0000641960" dictionary="Cancer.gov" audience="Patient"/></ListItem><ListItem>Pain where there is swelling or a lump over a bone.</ListItem></ItemizedList><Para id="_449">Children with LCH lesions in bones  around the ears or eyes have a high risk of <GlossaryTermRef href="CDR0000683346" dictionary="Cancer.gov" audience="Patient">diabetes insipidus</GlossaryTermRef> and other <GlossaryTermRef href="CDR0000046481" dictionary="Cancer.gov" audience="Patient">central nervous system</GlossaryTermRef> diseases.</Para></SummarySection><SummarySection id="_181"><KeyPoint id="_182">Skin and nails</KeyPoint><Para id="_292">LCH in infants may affect the skin only. In some cases, skin-only LCH may get worse over weeks or months and become a form called high-risk multisystem LCH. </Para><Para id="_448">In infants, signs or symptoms of LCH that affects the skin may include:</Para><ItemizedList id="_293" Style="bullet"><ListItem>	Flaking of the scalp that may look like “cradle cap.”</ListItem><ListItem>Flaking in the creases of the body, such as the inner elbow or <GlossaryTermRef href="CDR0000321384" dictionary="Cancer.gov" audience="Patient">perineum</GlossaryTermRef>.</ListItem><ListItem>Raised skin  <GlossaryTermRef href="CDR0000798604" dictionary="Cancer.gov" audience="Patient">rash</GlossaryTermRef> with brown or purple areas that occur anywhere on the body. </ListItem></ItemizedList><Para id="_184">In children and adults, signs or symptoms of LCH that affects the skin and nails may include:</Para><ItemizedList id="_294" Style="bullet"><ListItem>	Flaking of the scalp that may look like dandruff.</ListItem><ListItem>	Raised skin rash with red, brown, or crusted areas that may be itchy or painful. The rash can occur in the <GlossaryTermRef href="CDR0000046375" dictionary="Cancer.gov" audience="Patient">groin</GlossaryTermRef> area or on the <GlossaryTermRef href="CDR0000045070" dictionary="Cancer.gov" audience="Patient">abdomen</GlossaryTermRef>, back, or chest.</ListItem><ListItem>Bumps or <GlossaryTermRef href="CDR0000269469" dictionary="Cancer.gov" audience="Patient">ulcers</GlossaryTermRef> on the scalp.</ListItem><ListItem>Ulcers behind the ears, under the <GlossaryTermRef href="CDR0000304766" dictionary="Cancer.gov" audience="Patient">breasts</GlossaryTermRef>, or in the groin area.</ListItem><ListItem>Fingernails that fall off or have  discolored grooves that run across the nail.</ListItem></ItemizedList></SummarySection><SummarySection id="_185"><KeyPoint id="_186">Mouth</KeyPoint><Para id="_187">Signs or symptoms of LCH that affects the mouth may include:</Para><ItemizedList id="_295" Style="bullet"><ListItem>Swollen <GlossaryTermRef href="CDR0000481753" dictionary="Cancer.gov" audience="Patient">gums</GlossaryTermRef>.</ListItem><ListItem>Sores on the roof of the mouth, inside the cheeks, or on the tongue or lips.</ListItem><ListItem>Teeth that become uneven or fall out.</ListItem></ItemizedList></SummarySection><SummarySection id="_191"><KeyPoint id="_192">Lymph nodes and thymus</KeyPoint><Para id="_328">Signs or symptoms of LCH that affects the <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046616" dictionary="Cancer.gov" audience="Patient">thymus</GlossaryTermRef> may include:</Para><ItemizedList id="_329" Style="bullet"><ListItem>Swollen lymph nodes.</ListItem><ListItem>Cough, trouble breathing, or fast breathing.</ListItem><ListItem><GlossaryTermRef href="CDR0000044830" dictionary="Cancer.gov" audience="Patient">Superior vena cava syndrome</GlossaryTermRef>. This can cause coughing, trouble breathing, and swelling of the face, neck, and upper arms. For more information, see <SummaryRef href="CDR0000352193" url="/about-cancer/treatment/side-effects/cardiopulmonary-pdq">Cardiopulmonary Syndromes</SummaryRef>.</ListItem></ItemizedList></SummarySection><SummarySection id="_194"><KeyPoint id="_195">Endocrine system </KeyPoint><Para id="_330">Signs or symptoms of LCH that affects the <GlossaryTermRef href="CDR0000046229" dictionary="Cancer.gov" audience="Patient">pituitary gland</GlossaryTermRef> may include:</Para><ItemizedList id="_331" Style="bullet"><ListItem>Diabetes insipidus. This can cause a strong thirst and frequent <GlossaryTermRef href="CDR0000046642" dictionary="Cancer.gov" audience="Patient">urination</GlossaryTermRef>.</ListItem><ListItem>Slow growth.</ListItem><ListItem>Early or late <GlossaryTermRef href="CDR0000440113" dictionary="Cancer.gov" audience="Patient">puberty</GlossaryTermRef>.</ListItem><ListItem>Being very <GlossaryTermRef href="CDR0000304742" dictionary="Cancer.gov" audience="Patient">overweight</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_450">Signs or symptoms of LCH that affects the <GlossaryTermRef href="CDR0000046036" dictionary="Cancer.gov" audience="Patient">thyroid</GlossaryTermRef> may include:</Para><ItemizedList id="_451" Style="bullet"><ListItem>Swollen thyroid gland.</ListItem><ListItem><GlossaryTermRef href="CDR0000044547" dictionary="Cancer.gov" audience="Patient">Hypothyroidism</GlossaryTermRef>. This can cause tiredness, lack of energy, being sensitive to cold, <GlossaryTermRef href="CDR0000407757" dictionary="Cancer.gov" audience="Patient">constipation</GlossaryTermRef>, dry skin, thinning hair,  memory problems, trouble concentrating, and <GlossaryTermRef href="CDR0000430479" dictionary="Cancer.gov" audience="Patient">depression</GlossaryTermRef>. In infants, this can also cause a loss of <GlossaryTermRef href="CDR0000454699" dictionary="Cancer.gov" audience="Patient">appetite</GlossaryTermRef> and choking on food. In children and adolescents, this can cause behavior problems, weight gain, slow growth, and late puberty.</ListItem><ListItem>Trouble breathing.</ListItem></ItemizedList></SummarySection><SummarySection id="_473"><KeyPoint id="_474">Eye</KeyPoint><Para id="_475">Signs or symptoms of LCH that affects the eye may include:</Para><ItemizedList id="_476" Style="bullet"><ListItem>Vision problems or blindness.</ListItem></ItemizedList></SummarySection><SummarySection id="_210"><KeyPoint id="_211">Central nervous system (CNS)</KeyPoint><Para id="_334">Signs or symptoms of LCH that affects the CNS (<GlossaryTermRef href="CDR0000797669" dictionary="Cancer.gov" audience="Patient">brain</GlossaryTermRef> and <GlossaryTermRef href="CDR0000340937" dictionary="Cancer.gov" audience="Patient">spinal cord</GlossaryTermRef>) may include:</Para><ItemizedList id="_335" Style="bullet"><ListItem>Loss of balance, uncoordinated body movements, and trouble walking.</ListItem><ListItem>Trouble speaking.</ListItem><ListItem>Trouble seeing.</ListItem><ListItem>Headaches.</ListItem><ListItem>Changes in behavior or personality.</ListItem><ListItem>Memory problems.</ListItem></ItemizedList><Para id="_452">These signs and symptoms may be caused by lesions in the CNS or by CNS <GlossaryTermRef href="CDR0000687218" dictionary="Cancer.gov" audience="Patient">neurodegenerative syndrome</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_296"><KeyPoint id="_297">Liver and spleen</KeyPoint><Para id="_336">Signs or symptoms of LCH that affects the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">spleen</GlossaryTermRef> may include:</Para><ItemizedList id="_337" Style="bullet"><ListItem>Swelling in the abdomen caused by a buildup of extra <GlossaryTermRef href="CDR0000044669" dictionary="Cancer.gov" audience="Patient">fluid</GlossaryTermRef>.</ListItem><ListItem>Trouble breathing.</ListItem><ListItem>Yellowing of the skin and whites of the eyes.</ListItem><ListItem>Itching.</ListItem><ListItem>Easy bruising or bleeding.</ListItem><ListItem>Feeling very tired.</ListItem><ListItem><GlossaryTermRef href="CDR0000306496" dictionary="Cancer.gov" audience="Patient">Diarrhea</GlossaryTermRef>.</ListItem><ListItem>Bloody <GlossaryTermRef href="CDR0000046605" dictionary="Cancer.gov" audience="Patient">stools</GlossaryTermRef>.</ListItem></ItemizedList></SummarySection><SummarySection id="_201"><KeyPoint id="_202">Lung</KeyPoint><Para id="_338">Signs or symptoms of LCH that affects the <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lung</GlossaryTermRef> may include:</Para><ItemizedList id="_339" Style="bullet"><ListItem>Collapsed lung. This  condition can cause chest pain or tightness, trouble breathing, feeling tired, and a bluish color to the skin.</ListItem><ListItem>Trouble breathing, especially in adults who smoke.</ListItem><ListItem>Dry cough.</ListItem><ListItem>Chest pain.</ListItem></ItemizedList></SummarySection><SummarySection id="_204"><KeyPoint id="_205">Bone marrow</KeyPoint><Para id="_340">Signs or symptoms of LCH that affects the <GlossaryTermRef href="CDR0000045622" dictionary="Cancer.gov" audience="Patient">bone marrow</GlossaryTermRef> may include:</Para><ItemizedList id="_341" Style="bullet"><ListItem>Easy bruising or bleeding.</ListItem><ListItem><GlossaryTermRef href="CDR0000450108" dictionary="Cancer.gov" audience="Patient">Fever</GlossaryTermRef>.</ListItem><ListItem>Frequent infections.</ListItem></ItemizedList></SummarySection></SummarySection><SummarySection id="_279"><SectMetaData><SectionType>Diagnostic tests</SectionType></SectMetaData><KeyPoint id="_18">Tests that examine the organs and body systems where LCH may occur are  used to diagnose  LCH.</KeyPoint><Para id="_19">In addition to asking about your <GlossaryTermRef href="CDR0000798522" dictionary="Cancer.gov" audience="Patient">health history</GlossaryTermRef> and doing a <GlossaryTermRef href="CDR0000270871" dictionary="Cancer.gov" audience="Patient">physical exam</GlossaryTermRef>, your doctor may perform the following tests and procedures to <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef> LCH or conditions caused by LCH:</Para><ItemizedList id="_20" Style="bullet"><ListItem><Strong><GlossaryTermRef href="CDR0000729979" dictionary="Cancer.gov" audience="Patient">Complete blood count (CBC) with differential</GlossaryTermRef></Strong>: A procedure in which a sample of <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef> is drawn and checked for the following:<ItemizedList id="_246" Style="dash"><ListItem>The amount of <GlossaryTermRef href="CDR0000045108" dictionary="Cancer.gov" audience="Patient">hemoglobin</GlossaryTermRef> (the <GlossaryTermRef href="CDR0000046092" dictionary="Cancer.gov" audience="Patient">protein</GlossaryTermRef> that carries <GlossaryTermRef href="CDR0000538149" dictionary="Cancer.gov" audience="Patient">oxygen</GlossaryTermRef>) in the <GlossaryTermRef href="CDR0000046124" dictionary="Cancer.gov" audience="Patient">red blood cells</GlossaryTermRef>.</ListItem><ListItem>	The portion of the blood sample made up of red blood cells.
</ListItem><ListItem>The number and type of <GlossaryTermRef href="CDR0000045993" dictionary="Cancer.gov" audience="Patient">white blood cells</GlossaryTermRef>.</ListItem><ListItem>The number of red blood cells and <GlossaryTermRef href="CDR0000045840" dictionary="Cancer.gov" audience="Patient">platelets</GlossaryTermRef>.</ListItem></ItemizedList></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000304685" dictionary="Cancer.gov" audience="Patient">Blood chemistry studies</GlossaryTermRef></Strong>: A procedure in which a blood sample is checked to measure the amounts of certain substances released into the body by <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organs</GlossaryTermRef> and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease.</ListItem>
    <ListItem><Strong><GlossaryTermRef href="CDR0000390293" dictionary="Cancer.gov" audience="Patient">Liver function test</GlossaryTermRef></Strong>: A <GlossaryTermRef href="CDR0000688783" dictionary="Cancer.gov" audience="Patient">blood test</GlossaryTermRef> to measure the blood levels of certain substances released by the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef>. A high or low level of these substances can be a sign of disease in the liver.</ListItem><ListItem><Strong><GeneName>BRAF</GeneName> <GlossaryTermRef href="CDR0000046128" dictionary="Cancer.gov" audience="Patient">gene testing</GlossaryTermRef></Strong>: A <GlossaryTermRef href="CDR0000046590" dictionary="Cancer.gov" audience="Patient">laboratory test</GlossaryTermRef> in which a sample of blood or tissue is tested for certain mutations in the <GeneName>BRAF</GeneName> gene. </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046641" dictionary="Cancer.gov" audience="Patient">Urinalysis</GlossaryTermRef></Strong>: A test to check the color of <GlossaryTermRef href="CDR0000046642" dictionary="Cancer.gov" audience="Patient">urine</GlossaryTermRef> and its contents, such as sugar, protein, red blood cells, and white blood cells.  </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000683536" dictionary="Cancer.gov" audience="Patient">Water deprivation test</GlossaryTermRef></Strong>: A test to check how much urine is made and whether it becomes concentrated when little or no water is given. This test is used to diagnose diabetes insipidus, which may be caused by LCH.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000669655" dictionary="Cancer.gov" audience="Patient">Bone marrow aspiration and biopsy</GlossaryTermRef></Strong>: The removal of <GlossaryTermRef href="CDR0000045622" dictionary="Cancer.gov" audience="Patient">bone marrow</GlossaryTermRef> and a small piece of bone by inserting a hollow needle into the hipbone. A <GlossaryTermRef href="CDR0000046244" dictionary="Cancer.gov" audience="Patient">pathologist</GlossaryTermRef> views the bone marrow and bone under a <GlossaryTermRef href="CDR0000638184" dictionary="Cancer.gov" audience="Patient">microscope</GlossaryTermRef> to  look for signs of LCH. <MediaLink ref="CDR0000554337" type="image/jpeg" alt="Bone marrow aspiration and biopsy; drawing shows a patient lying face down on a table and a bone marrow needle being inserted into the hip bone. An inset shows a close up of the needle being inserted through the skin and hip bone into the bone marrow." language="en" placement="image-center" id="_352"><Caption language="en">Bone marrow aspiration and biopsy. After a small area of skin is numbed, a long, hollow needle is inserted through the patient's skin and hip bone into the bone marrow. A sample of bone marrow and a small piece of bone are removed for examination under a microscope.</Caption></MediaLink><Para id="_444">The following test may be done on the tissue that was removed:</Para><ItemizedList id="_445" Style="bullet"><ListItem><Strong><GlossaryTermRef href="CDR0000653117" dictionary="Cancer.gov" audience="Patient">Immunohistochemistry</GlossaryTermRef></Strong>: A laboratory test that uses <GlossaryTermRef href="CDR0000044918" dictionary="Cancer.gov" audience="Patient">antibodies</GlossaryTermRef> to check for certain <GlossaryTermRef href="CDR0000046086" dictionary="Cancer.gov" audience="Patient">antigens</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045776" dictionary="Cancer.gov" audience="Patient">markers</GlossaryTermRef>) in a sample of a patient’s tissue. The antibodies are usually linked to an <GlossaryTermRef href="CDR0000046081" dictionary="Cancer.gov" audience="Patient">enzyme</GlossaryTermRef> or a fluorescent dye. After the antibodies bind to a specific antigen in the tissue sample, the enzyme or dye is activated, and the antigen can then be seen under a microscope. This type of test is used to help diagnose cancer and to help tell one type of cancer from another type of cancer.</ListItem></ItemizedList></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046499" dictionary="Cancer.gov" audience="Patient">Bone scan</GlossaryTermRef></Strong>: A procedure to check if there are rapidly dividing cells in the bone. A very small amount of <GlossaryTermRef href="CDR0000046550" dictionary="Cancer.gov" audience="Patient">radioactive</GlossaryTermRef> material is <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef> and travels through the bloodstream. The radioactive material collects in the bones with LCH and is detected by a <GlossaryTermRef href="CDR0000386220" dictionary="Cancer.gov" audience="Patient">scanner</GlossaryTermRef>.<MediaLink ref="CDR0000775451" type="image/jpeg" alt="Bone scan; drawing shows a child lying on a table that slides under the scanner, a technician operating the scanner, and a computer monitor that will show images made during the scan." language="en" placement="image-center" id="_465"><Caption language="en">Bone scan.  A small amount of radioactive material is injected into the child's vein and travels through the blood. The radioactive material collects in the bones. As the child lies on a table that slides under the scanner, the radioactive material is detected and images are made on a computer screen.</Caption></MediaLink> </ListItem>
    <ListItem><Strong><GlossaryTermRef href="CDR0000045944" dictionary="Cancer.gov" audience="Patient">X-ray</GlossaryTermRef></Strong>: An x-ray of the organs and bones inside the body. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body. Sometimes a <GlossaryTermRef href="CDR0000044350" dictionary="Cancer.gov" audience="Patient">skeletal</GlossaryTermRef> survey is done. This is a procedure to x-ray all the bones in the body.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046033" dictionary="Cancer.gov" audience="Patient">CT scan</GlossaryTermRef> (CAT scan)</Strong>: A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.<MediaLink ref="CDR0000428405" type="image/jpeg" alt="Computed tomography (CT) scan of the abdomen; drawing shows the patient on a table that slides through the CT machine, which takes x-ray pictures of the inside of the body." language="en" placement="image-center" id="_354"><Caption language="en">Computed tomography (CT) scan of the abdomen.  The patient lies on a table that slides through the CT machine, which takes x-ray pictures of the inside of the body.</Caption></MediaLink></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045788" dictionary="Cancer.gov" audience="Patient">MRI</GlossaryTermRef> (magnetic resonance imaging)</Strong>: A procedure that uses a magnet, <GlossaryTermRef href="CDR0000651209" dictionary="Cancer.gov" audience="Patient">radio waves</GlossaryTermRef>, and a computer to make a series of detailed pictures of areas inside the body. A substance called <GlossaryTermRef href="CDR0000597153" dictionary="Cancer.gov" audience="Patient">gadolinium</GlossaryTermRef> may be injected into a vein. The gadolinium collects around the LCH cells so that they show up brighter in the picture. This procedure is also called  nuclear magnetic resonance imaging (NMRI).<MediaLink ref="CDR0000775532" type="image/jpeg" alt="Magnetic resonance imaging (MRI) scan; drawing shows a child lying on a table that slides into the MRI machine, which takes a series of detailed pictures of areas inside the body." language="en" placement="image-center" id="_466"><Caption language="en">Magnetic resonance imaging (MRI) scan. The child lies on a table that slides into the MRI machine, which takes a series of detailed pictures of areas inside the body. The positioning of the child on the table depends on the part of the body being imaged.</Caption></MediaLink></ListItem>
    <ListItem><Strong><GlossaryTermRef href="CDR0000046140" dictionary="Cancer.gov" audience="Patient">PET scan</GlossaryTermRef> (positron emission tomography scan)</Strong>: A procedure to find <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef> cells in the body. A small amount of radioactive <GlossaryTermRef href="CDR0000044033" dictionary="Cancer.gov" audience="Patient">glucose</GlossaryTermRef> (sugar) is injected into a vein. The PET scanner rotates around the body and makes a picture of where glucose is being used in the body. Tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.<MediaLink ref="CDR0000775456" type="image/jpeg" alt="Positron emission tomography (PET) scan; drawing shows a child lying on table that slides through the PET scanner." language="en" placement="image-center" id="_467"><Caption language="en">Positron emission tomography (PET) scan. The child lies on a table that slides through the PET scanner. The head rest and white strap help the child lie still.  A small amount of radioactive glucose (sugar) is injected into the child's vein, and a scanner makes a picture of where the glucose is being used in the body.  Cancer cells show up brighter in the picture because they take up more glucose than normal cells do. </Caption></MediaLink></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046157" dictionary="Cancer.gov" audience="Patient">Ultrasound</GlossaryTermRef> exam</Strong>: A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a <GlossaryTermRef href="CDR0000046587" dictionary="Cancer.gov" audience="Patient">sonogram</GlossaryTermRef>. The picture can be printed to be looked at later.<MediaLink ref="CDR0000618022" type="image/jpeg" alt="Abdominal ultrasound; drawing shows a woman on an exam table during an abdominal ultrasound procedure. A diagnostic sonographer (a person trained to perform ultrasound procedures) is shown passing a transducer (a device that makes sound waves that bounce off tissues inside the body) over the surface of the patient’s abdomen. A computer screen shows a sonogram (computer picture)." language="en" placement="image-center" id="_468"><Caption language="en">Abdominal ultrasound. An ultrasound transducer connected to a computer is passed over the surface of the abdomen. The ultrasound transducer bounces sound waves off internal organs and tissues to make echoes that form a sonogram (computer picture).</Caption></MediaLink></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000658018" dictionary="Cancer.gov" audience="Patient">Pulmonary function test</GlossaryTermRef> (PFT)</Strong>: A test to see how well the lungs are working. It measures how much air the lungs can hold and how quickly air moves into and out of the lungs. It also measures how much oxygen is used and how much <GlossaryTermRef href="CDR0000538147" dictionary="Cancer.gov" audience="Patient">carbon dioxide</GlossaryTermRef> is given off during breathing. This is also called lung function test.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045628" dictionary="Cancer.gov" audience="Patient">Bronchoscopy</GlossaryTermRef></Strong>: A procedure to look inside the <GlossaryTermRef href="CDR0000046623" dictionary="Cancer.gov" audience="Patient">trachea</GlossaryTermRef> and large airways in the lung for <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> areas. A <GlossaryTermRef href="CDR0000046496" dictionary="Cancer.gov" audience="Patient">bronchoscope</GlossaryTermRef>  is inserted through the nose or mouth into the trachea and lungs.  A bronchoscope is a thin, tube-like instrument with a light and a <GlossaryTermRef href="CDR0000572035" dictionary="Cancer.gov" audience="Patient">lens</GlossaryTermRef> for viewing. It may also have a  tool to remove tissue samples, which are checked under a microscope for signs of LCH.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045678" dictionary="Cancer.gov" audience="Patient">Endoscopy</GlossaryTermRef></Strong>: A procedure to look at organs and tissues inside the body to check for <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> areas in the <GlossaryTermRef href="CDR0000046189" dictionary="Cancer.gov" audience="Patient">gastrointestinal tract</GlossaryTermRef> or lungs. An <GlossaryTermRef href="CDR0000046428" dictionary="Cancer.gov" audience="Patient">endoscope</GlossaryTermRef> is inserted through an <GlossaryTermRef href="CDR0000046353" dictionary="Cancer.gov" audience="Patient">incision</GlossaryTermRef> (cut) in the skin or opening in the body, such as the mouth. An endoscope is a thin, tube-like instrument with a light and a <GlossaryTermRef href="CDR0000572035" dictionary="Cancer.gov" audience="Patient">lens</GlossaryTermRef> for viewing. It may also have a tool to remove tissue or lymph node samples, which are checked under a microscope for signs of disease.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045164" dictionary="Cancer.gov" audience="Patient">Biopsy</GlossaryTermRef></Strong>: The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for LCH cells. To diagnose LCH, a biopsy of bone, skin, lymph nodes, liver, or other sites of disease  may be done.</ListItem>
   </ItemizedList></SummarySection><SummarySection id="_21"><SectMetaData><SectionType>Prognostic factors</SectionType></SectMetaData><KeyPoint id="_22">Certain factors affect prognosis (chance of recovery) and treatment options.</KeyPoint><Para id="_299">LCH in organs such as the skin, bones, lymph nodes, or <GlossaryTermRef href="CDR0000046229" dictionary="Cancer.gov" audience="Patient">pituitary gland</GlossaryTermRef> usually gets better with treatment and is called "low-risk." LCH in the <GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">spleen</GlossaryTermRef>, liver, or bone marrow is harder to treat and is called "high-risk." Children with LCH in high-risk organs and the <GlossaryTermRef href="CDR0000046189" dictionary="Cancer.gov" audience="Patient">gastrointestinal tract</GlossaryTermRef> have a greater risk of not <GlossaryTermRef href="CDR0000044085" dictionary="Cancer.gov" audience="Patient">responding</GlossaryTermRef> to treatment than patients with high-risk LCH and no disease in the gastrointestinal tract. High-risk LCH is usually seen in children younger than 2 years.</Para><Para id="_23">The <GlossaryTermRef href="CDR0000045849" dictionary="Cancer.gov" audience="Patient">prognosis</GlossaryTermRef> and treatment options depend on the following: </Para><ItemizedList id="_24" Style="bullet">
    <ListItem>Which organs or body systems are affected by LCH.</ListItem><ListItem>How many organs or body systems the LCH affects.</ListItem><ListItem>Whether LCH is found in the liver, spleen, bone marrow, or certain bones in the skull.</ListItem>
    <ListItem>How quickly LCH responds to initial treatment.</ListItem>
    <ListItem>Whether there are certain mutations in the <GeneName>BRAF</GeneName> gene.</ListItem><ListItem>Whether LCH has just been diagnosed or has come back (<GlossaryTermRef href="CDR0000046556" dictionary="Cancer.gov" audience="Patient">recurred</GlossaryTermRef>).</ListItem>
   </ItemizedList><Para id="_300">In infants up to 1 year of age,  LCH may go away without treatment.</Para></SummarySection></SummarySection><SummarySection id="_301"><Title>Stages of LCH</Title><SummarySection id="_342"><KeyPoint id="_343">There is no standard staging system for Langerhans cell histiocytosis (LCH).</KeyPoint><Para id="_344">The process used to find out if<GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient"> cancer</GlossaryTermRef> has spread to other parts of the body is called <GlossaryTermRef href="CDR0000046597" dictionary="Cancer.gov" audience="Patient">staging</GlossaryTermRef>. There is no standard <GlossaryTermRef href="CDR0000689095" dictionary="Cancer.gov" audience="Patient">staging system</GlossaryTermRef> for <GlossaryTermRef href="CDR0000513054" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef>. </Para></SummarySection><SummarySection id="_304"><KeyPoint id="_305">Treatment of LCH is based on where LCH cells are found in the body and whether the LCH is low risk or high risk.</KeyPoint><Para id="_360">LCH is described as single-system  disease or multisystem disease, depending on how many body systems are affected: </Para><ItemizedList id="_361" Style="bullet">
     <ListItem><Strong>Single-system LCH:</Strong> LCH is found in  one part of an <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organ</GlossaryTermRef> or body system or in more than one part of that organ or body system. Bone is the most common single place for LCH to be found.</ListItem><ListItem><Strong>Multisystem LCH:</Strong> LCH is found in two or more organs or body systems or may be found throughout the body. Multisystem LCH is less common than single-system LCH.</ListItem></ItemizedList><Para id="_362">LCH may affect low-risk organs or high-risk organs:</Para><ItemizedList id="_363" Style="bullet">
     <ListItem><Strong>Low-risk organs</Strong> include the skin, bone, <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lungs</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046189" dictionary="Cancer.gov" audience="Patient">gastrointestinal tract</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046229" dictionary="Cancer.gov" audience="Patient">pituitary gland</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046036" dictionary="Cancer.gov" audience="Patient">thyroid gland</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046616" dictionary="Cancer.gov" audience="Patient">thymus</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046481" dictionary="Cancer.gov" audience="Patient">central nervous system</GlossaryTermRef> (CNS).</ListItem><ListItem><Strong>High-risk organs</Strong> include the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">spleen</GlossaryTermRef>,  and <GlossaryTermRef href="CDR0000045622" dictionary="Cancer.gov" audience="Patient">bone marrow</GlossaryTermRef>.</ListItem></ItemizedList></SummarySection><SummarySection id="_4802"><KeyPoint id="_4803">Sometimes LCH continues to grow or comes back after treatment.</KeyPoint><Para id="_4805"><GlossaryTermRef href="CDR0000045850" dictionary="Cancer.gov" audience="Patient">Progressive</GlossaryTermRef> LCH describes LCH  that continues to grow, spread, or get worse. Progressive disease may be a sign that the LCH has become <GlossaryTermRef href="CDR0000350245" dictionary="Cancer.gov" audience="Patient">refractory</GlossaryTermRef> to treatment.</Para><Para id="_4806">Refractory LCH describes LCH  that does not <GlossaryTermRef href="CDR0000044085" dictionary="Cancer.gov" audience="Patient">respond</GlossaryTermRef> to initial treatment. </Para><Para id="_347"><GlossaryTermRef href="CDR0000045862" dictionary="Cancer.gov" audience="Patient">Recurrent</GlossaryTermRef>  or <GlossaryTermRef href="CDR0000683532" dictionary="Cancer.gov" audience="Patient">reactivated</GlossaryTermRef> LCH describes LCH that has come back after it has been treated. </Para><Para id="_4807">Many patients with LCH  get better with treatment. However, when treatment stops, new <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> may appear or old lesions may come back. This is called reactivation (recurrence) and may  occur within 1  year after stopping treatment. Patients with multisystem disease are more likely to have a reactivation. Common  sites of reactivation are bone, ears, or skin. <GlossaryTermRef href="CDR0000683346" dictionary="Cancer.gov" audience="Patient">Diabetes insipidus</GlossaryTermRef> also may  develop. Less common sites of reactivation include lymph nodes, bone marrow, spleen, liver, or lung. Some patients may have more than one reactivation.</Para></SummarySection></SummarySection><SummarySection id="_52"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><Title>Treatment Option Overview for LCH</Title><SummarySection id="_276"><KeyPoint id="_53">There are different types of treatment for patients with Langerhans cell histiocytosis (LCH).</KeyPoint><Para id="_54">Different types of treatments are available for patients with <GlossaryTermRef href="CDR0000513054" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef>. Some treatments are <GlossaryTermRef href="CDR0000044930" dictionary="Cancer.gov" audience="Patient">standard</GlossaryTermRef> (the currently used treatment), and some are being tested in <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trials</GlossaryTermRef>. A treatment clinical trial is a <GlossaryTermRef href="CDR0000651211" dictionary="Cancer.gov" audience="Patient">research study</GlossaryTermRef> meant to help improve current treatments or obtain information on new treatments for patients with <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>. When clinical trials show that a new treatment is better than the  standard treatment, the new treatment may become the standard treatment. Whenever possible,  patients should take part in a clinical trial in order to receive new types of treatment for LCH. Some clinical trials are open only to patients  who have not started treatment.</Para><Para id="_55">Clinical trials are taking place in many parts of the country. Information about ongoing clinical trials is available from the <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI website</ExternalRef>. Choosing the most appropriate treatment is a decision that ideally involves the patient, family, and health care team.</Para></SummarySection><SummarySection id="_56"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_57">Children with LCH should have their treatment planned by a team of health care providers who are experts in treating childhood cancer or LCH. </KeyPoint><Para id="_58">Treatment will be overseen by a <GlossaryTermRef href="CDR0000693555" dictionary="Cancer.gov" audience="Patient">pediatric oncologist</GlossaryTermRef>, a doctor who specializes in treating children with    cancer. The pediatric oncologist works with other <GlossaryTermRef href="CDR0000046245" dictionary="Cancer.gov" audience="Patient">pediatric</GlossaryTermRef> <GlossaryTermRef href="CDR0000650566" dictionary="Cancer.gov" audience="Patient">health care providers</GlossaryTermRef>  who are experts in treating children with LCH and who specialize in certain areas of <GlossaryTermRef href="CDR0000482419" dictionary="Cancer.gov" audience="Patient">medicine</GlossaryTermRef>. These may include the following <GlossaryTermRef href="CDR0000478785" dictionary="Cancer.gov" audience="Patient">specialists</GlossaryTermRef>: </Para><ItemizedList id="_59" Style="bullet">
    <ListItem><GlossaryTermRef href="CDR0000757278" dictionary="Cancer.gov" audience="Patient">Pediatrician</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000318823" dictionary="Cancer.gov" audience="Patient">Pediatric surgeon</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000318822" dictionary="Cancer.gov" audience="Patient">Pediatric hematologist</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000046546" dictionary="Cancer.gov" audience="Patient">Radiation oncologist</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000046267" dictionary="Cancer.gov" audience="Patient">Neurologist</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000046439" dictionary="Cancer.gov" audience="Patient">Endocrinologist</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000318821" dictionary="Cancer.gov" audience="Patient">Pediatric nurse specialist</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000318825" dictionary="Cancer.gov" audience="Patient">Rehabilitation specialist</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000044716" dictionary="Cancer.gov" audience="Patient">Psychologist</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000044730" dictionary="Cancer.gov" audience="Patient">Social worker</GlossaryTermRef>.</ListItem>
    
   </ItemizedList></SummarySection><SummarySection id="_63"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_64">Nine types of standard treatment are used to treat LCH.</KeyPoint><Para id="_4811">Although it is unknown whether LCH is a type of cancer, some of the treatments used for cancer are effective at treating LCH.</Para><SummarySection id="_72"><KeyPoint id="_73">Chemotherapy</KeyPoint><Para id="_74">
     <GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> is a cancer treatment that uses <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drugs</GlossaryTermRef> to stop the growth of cancer <GlossaryTermRef href="CDR0000046476" dictionary="Cancer.gov" audience="Patient">cells</GlossaryTermRef>, either by killing the cells or by stopping them from dividing.   Chemotherapy that  is taken by mouth or <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef> or muscle enters the bloodstream and can reach cancer cells throughout the body (<GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>).  Chemotherapy may also be applied to the skin in a cream or lotion (<GlossaryTermRef href="CDR0000046619" dictionary="Cancer.gov" audience="Patient">topical chemotherapy</GlossaryTermRef>).
    </Para><Para id="_264">Chemotherapy may be given by injection, by mouth, or applied to the skin to treat LCH. </Para></SummarySection><SummarySection id="_65"><KeyPoint id="_66">Surgery</KeyPoint><Para id="_67"><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef> may be used to remove LCH <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> and a small amount of nearby healthy <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef>. <GlossaryTermRef href="CDR0000046459" dictionary="Cancer.gov" audience="Patient">Curettage</GlossaryTermRef> is a type of surgery that uses a <GlossaryTermRef href="CDR0000046460" dictionary="Cancer.gov" audience="Patient">curette</GlossaryTermRef> (a sharp, spoon-shaped tool) to scrape LCH cells from bone.</Para><Para id="_453">When there is severe <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef> or <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lung</GlossaryTermRef> damage, the entire organ may be removed and replaced with a healthy liver or lung from a <GlossaryTermRef href="CDR0000643010" dictionary="Cancer.gov" audience="Patient">donor</GlossaryTermRef>. </Para></SummarySection><SummarySection id="_433"><KeyPoint id="_434">Radiation therapy</KeyPoint><Para id="_435"><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">Radiation therapy</GlossaryTermRef> is a cancer treatment that uses high-energy <GlossaryTermRef href="CDR0000045944" dictionary="Cancer.gov" audience="Patient">x-rays</GlossaryTermRef> or other types of <GlossaryTermRef href="CDR0000045072" dictionary="Cancer.gov" audience="Patient">radiation</GlossaryTermRef> to kill cancer cells or keep them from growing. <GlossaryTermRef href="CDR0000046686" dictionary="Cancer.gov" audience="Patient">External radiation therapy</GlossaryTermRef> uses a machine outside the body to send radiation toward the area of the body with cancer. <GlossaryTermRef href="CDR0000666695" dictionary="Cancer.gov" audience="Patient">Ultraviolet B</GlossaryTermRef> (UVB) radiation therapy may be given using a special lamp that directs radiation toward LCH skin lesions.</Para></SummarySection><SummarySection id="_436"><KeyPoint id="_437">Photodynamic therapy</KeyPoint><Para id="_438"><GlossaryTermRef href="CDR0000045238" dictionary="Cancer.gov" audience="Patient">Photodynamic therapy</GlossaryTermRef> is a cancer treatment that uses a drug and a certain type of <GlossaryTermRef href="CDR0000045748" dictionary="Cancer.gov" audience="Patient">laser</GlossaryTermRef> light to kill cancer cells. A drug that is not active until it is exposed to light is injected into a vein. The drug collects more in cancer cells than in normal cells. For LCH, laser light is aimed at the skin and the drug becomes active and kills the cancer cells. Photodynamic therapy causes little damage to healthy tissue. Patients who have photodynamic therapy should not spend too much time in the sun.</Para><Para id="_439">In one
			 type of photodynamic therapy, called <GlossaryTermRef href="CDR0000439423" dictionary="Cancer.gov" audience="Patient">psoralen and ultraviolet A</GlossaryTermRef> (PUVA) therapy, the  patient receives a drug
			 called <GlossaryTermRef href="CDR0000044900" dictionary="Cancer.gov" audience="Patient">psoralen</GlossaryTermRef> and then
			 <GlossaryTermRef href="CDR0000666694" dictionary="Cancer.gov" audience="Patient">ultraviolet A radiation</GlossaryTermRef> is directed to
			 the skin.</Para></SummarySection><SummarySection id="_411"><KeyPoint id="_412">Immunotherapy</KeyPoint><Para id="_413"><GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">Immunotherapy</GlossaryTermRef> is a treatment that uses the patient’s <GlossaryTermRef href="CDR0000046356" dictionary="Cancer.gov" audience="Patient">immune system</GlossaryTermRef> to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body’s natural defenses against cancer. <GlossaryTermRef href="CDR0000045458" dictionary="Cancer.gov" audience="Patient">Thalidomide</GlossaryTermRef> is a type of immunotherapy used to treat LCH.</Para></SummarySection><SummarySection id="_422"><KeyPoint id="_423">Targeted therapy</KeyPoint><Para id="_424"><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. There are different types of targeted therapy:</Para><ItemizedList id="_482" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000750801" dictionary="Cancer.gov" audience="Patient">BRAF inhibitors</GlossaryTermRef> block <GlossaryTermRef href="CDR0000046092" dictionary="Cancer.gov" audience="Patient">proteins</GlossaryTermRef> needed for cell growth and may kill cancer cells. The <GeneName>BRAF</GeneName>  <GlossaryTermRef href="CDR0000045693" dictionary="Cancer.gov" audience="Patient">gene</GlossaryTermRef> is found in a <GlossaryTermRef href="CDR0000044133" dictionary="Cancer.gov" audience="Patient">mutated</GlossaryTermRef> (changed) form in some LCH and blocking it may help keep LCH cells from growing.<ItemizedList id="_484" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000702051" dictionary="Cancer.gov" audience="Patient">Vemurafenib</GlossaryTermRef> and <GlossaryTermRef href="CDR0000750069" dictionary="Cancer.gov" audience="Patient">dabrafenib</GlossaryTermRef> are BRAF inhibitors used to treat LCH.</ListItem></ItemizedList></ListItem><ListItem><GlossaryTermRef href="CDR0000798762" dictionary="Cancer.gov" audience="Patient">MEK inhibitors</GlossaryTermRef> block proteins called <GlossaryTermRef href="CDR0000800545" dictionary="Cancer.gov" audience="Patient">MEK1</GlossaryTermRef> and <GlossaryTermRef href="CDR0000800547" dictionary="Cancer.gov" audience="Patient">MEK2</GlossaryTermRef> that affect the growth and survival of cancer cells.<ItemizedList id="_4815" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000750072" dictionary="Cancer.gov" audience="Patient">Trametinib</GlossaryTermRef> is a MEK inhibitor that is being studied in the treatment of  certain childhood tumors for use alone or combined with <GlossaryTermRef href="CDR0000750069" dictionary="Cancer.gov" audience="Patient">dabrafenib</GlossaryTermRef>.</ListItem></ItemizedList></ListItem><ListItem><GlossaryTermRef href="CDR0000046066" dictionary="Cancer.gov" audience="Patient">Monoclonal
				antibodies</GlossaryTermRef> are <GlossaryTermRef href="CDR0000046356" dictionary="Cancer.gov" audience="Patient">immune system</GlossaryTermRef> <GlossaryTermRef href="CDR0000046092" dictionary="Cancer.gov" audience="Patient">proteins</GlossaryTermRef> made in the laboratory to treat many diseases, including cancer. As a cancer treatment, these antibodies can attach to a specific target on cancer cells or other cells that may help cancer cells grow.  The antibodies are able to then kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by <GlossaryTermRef href="CDR0000045738" dictionary="Cancer.gov" audience="Patient">infusion</GlossaryTermRef>. They may be used alone or to carry drugs, <GlossaryTermRef href="CDR0000046622" dictionary="Cancer.gov" audience="Patient">toxins</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000046550" dictionary="Cancer.gov" audience="Patient">radioactive</GlossaryTermRef> material directly to cancer cells.<ItemizedList id="_4804" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045525" dictionary="Cancer.gov" audience="Patient">Rituximab</GlossaryTermRef> is a monoclonal antibody used to treat LCH.</ListItem></ItemizedList><EmbeddedVideo id="_4813" ref="CDR0000801837" hosting="youtube" unique_id="dxnjAc-rqz8" language="en" audience="Patients" template="Video75NoTitle"><VideoTitle>monoclonal antibodies: how monoclonal antibodies treat cancer</VideoTitle><Caption language="en">How do  monoclonal antibodies work to treat cancer? This video shows how monoclonal antibodies, such as trastuzumab, pembrolizumab, and rituximab, block molecules cancer cells need to grow, flag cancer cells for destruction by the body’s immune system, or deliver harmful substances to cancer cells. </Caption></EmbeddedVideo></ListItem></ItemizedList></SummarySection><SummarySection id="_415"><KeyPoint id="_416">Other drug therapy</KeyPoint><Para id="_425">Other drugs used to treat LCH include the following:</Para><ItemizedList id="_426" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">Steroid therapy</GlossaryTermRef>, such as <GlossaryTermRef href="CDR0000045492" dictionary="Cancer.gov" audience="Patient">prednisone</GlossaryTermRef>, is used to treat LCH lesions.</ListItem><ListItem><GlossaryTermRef href="CDR0000044817" dictionary="Cancer.gov" audience="Patient">Bisphosphonate</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef> (such as <GlossaryTermRef href="CDR0000045175" dictionary="Cancer.gov" audience="Patient">pamidronate</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045500" dictionary="Cancer.gov" audience="Patient">zoledronate</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000045355" dictionary="Cancer.gov" audience="Patient">alendronate</GlossaryTermRef>) is used to treat LCH lesions of the bone and to lessen bone pain. </ListItem><ListItem><GlossaryTermRef href="CDR0000489392" dictionary="Cancer.gov" audience="Patient">Anti-inflammatory drugs</GlossaryTermRef> are drugs (such as  <GlossaryTermRef href="CDR0000410212" dictionary="Cancer.gov" audience="Patient">pioglitazone</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045083" dictionary="Cancer.gov" audience="Patient">rofecoxib</GlossaryTermRef>) that are commonly used to decrease <GlossaryTermRef href="CDR0000450108" dictionary="Cancer.gov" audience="Patient">fever</GlossaryTermRef>, swelling, pain, and redness. Anti-inflammatory drugs and chemotherapy may be given together to treat adults with bone LCH.</ListItem></ItemizedList></SummarySection><SummarySection id="_408"><KeyPoint id="_409">Stem cell transplant</KeyPoint><Para id="_410">Chemotherapy is given to kill cancer cells. Healthy cells, including blood-forming cells, are destroyed by the LCH treatment. <GlossaryTermRef href="CDR0000046695" dictionary="Cancer.gov" audience="Patient">Stem cell transplant</GlossaryTermRef> is a treatment to replace the blood-forming cells. Stem cells (immature blood cells) are removed from the blood or <GlossaryTermRef href="CDR0000045622" dictionary="Cancer.gov" audience="Patient">bone marrow</GlossaryTermRef> of the patient or a <GlossaryTermRef href="CDR0000643010" dictionary="Cancer.gov" audience="Patient">donor</GlossaryTermRef> and are frozen and stored. After the patient completes chemotherapy, the stored stem cells are thawed and given back to the patient through an <GlossaryTermRef href="CDR0000045738" dictionary="Cancer.gov" audience="Patient">infusion</GlossaryTermRef>. These stem cells grow into (and restore) the body's blood cells.

</Para></SummarySection><SummarySection id="_251"><KeyPoint id="_252">Observation</KeyPoint><Para id="_253"><GlossaryTermRef href="CDR0000045981" dictionary="Cancer.gov" audience="Patient">Observation</GlossaryTermRef> is closely <GlossaryTermRef href="CDR0000454803" dictionary="Cancer.gov" audience="Patient">monitoring</GlossaryTermRef> a patient's <GlossaryTermRef href="CDR0000651193" dictionary="Cancer.gov" audience="Patient">condition</GlossaryTermRef> without giving any treatment until <GlossaryTermRef href="CDR0000750109" dictionary="Cancer.gov" audience="Patient">signs</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> appear or change.</Para></SummarySection></SummarySection><SummarySection id="_87"><SectMetaData><SectionType>Treatment in clinical trials</SectionType></SectMetaData><KeyPoint id="_88">New types of treatment are being tested in clinical trials.</KeyPoint><Para id="http://cancer.gov/clinicaltrials"> Information about clinical trials is available from the <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI website</ExternalRef>.</Para></SummarySection><SummarySection id="_60"><SectMetaData><SectionType>Side effects of cancer treatment</SectionType></SectMetaData><KeyPoint id="_61">Treatment for Langerhans cell histiocytosis may cause side effects.</KeyPoint><Para id="_60_md_76">To learn more about <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef> that begin during treatment for cancer, visit <ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/side-effects">Side Effects</ExternalRef>.</Para><Para id="_458">Side effects from cancer treatment that begin after treatment and continue for months or years are called <GlossaryTermRef href="CDR0000390292" dictionary="Cancer.gov" audience="Patient">late effects</GlossaryTermRef>. Late effects of cancer treatment may include the following:</Para><ItemizedList id="_166" Style="bullet"><ListItem>Slow growth and development.</ListItem><ListItem><GlossaryTermRef href="CDR0000045713" dictionary="Cancer.gov" audience="Patient">Hormone</GlossaryTermRef> imbalance.</ListItem><ListItem>Hearing loss.</ListItem><ListItem>Bone, tooth, liver, and lung  problems.</ListItem><ListItem>Changes in mood, feeling, behavior, learning, thinking, or memory.</ListItem><ListItem><GlossaryTermRef href="CDR0000046658" dictionary="Cancer.gov" audience="Patient">Second cancers</GlossaryTermRef>, such as <GlossaryTermRef href="CDR0000045343" dictionary="Cancer.gov" audience="Patient">leukemia</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045368" dictionary="Cancer.gov" audience="Patient">lymphoma</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046774" dictionary="Cancer.gov" audience="Patient">retinoblastoma</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046031" dictionary="Cancer.gov" audience="Patient">Ewing sarcoma</GlossaryTermRef>,  <GlossaryTermRef href="CDR0000387264" dictionary="Cancer.gov" audience="Patient">brain</GlossaryTermRef> or <GlossaryTermRef href="CDR0000044242" dictionary="Cancer.gov" audience="Patient">liver cancer</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_167">Some late effects may be treated or controlled. It is important to talk with your child's doctors about the effects cancer treatment can have on your child. For more information, see <SummaryRef href="CDR0000373791" url="/types/childhood-cancers/late-effects-pdq">Late Effects of Treatment for Childhood Cancer</SummaryRef>.</Para><Para id="_443">Many patients with multisystem LCH have late effects caused by   treatment or     by the disease itself. These patients often have long-term health problems that affect their <GlossaryTermRef href="CDR0000045417" dictionary="Cancer.gov" audience="Patient">quality of life</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_168"><KeyPoint id="_169">Patients may want to think about taking part in a clinical trial.</KeyPoint><Para id="_168_md_23">For some patients, taking part in a <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trial</GlossaryTermRef> may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer  treatments are safe and effective or better than the <GlossaryTermRef href="CDR0000044930" dictionary="Cancer.gov" audience="Patient">standard treatment</GlossaryTermRef>.</Para><Para id="_168_md_24">Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first  to receive a new treatment.</Para><Para id="_168_md_25">Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.</Para></SummarySection><SummarySection id="_173"><KeyPoint id="_174">Patients can enter clinical trials before, during, or after starting their treatment.</KeyPoint><Para id="_173_md_29">Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef> of cancer treatment.</Para><Para id="_173_md_30">Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trials search</ExternalRef> webpage. Clinical trials supported by other organizations can be found on the <ExternalRef xref="https://clinicaltrials.gov/">ClinicalTrials.gov</ExternalRef> website.</Para></SummarySection><SummarySection id="_314"><KeyPoint id="_315">Follow-up tests may be needed.</KeyPoint><Para id="_316">LCH patients should be monitored for many years because of the risk of reactivation (<GlossaryTermRef href="CDR0000045861" dictionary="Cancer.gov" audience="Patient">recurrence</GlossaryTermRef>). Some of the tests that were done to <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef> LCH may be repeated. This is  to see how well the treatment is working and if there are any new lesions. These tests may include:</Para><ItemizedList id="_313" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000270871" dictionary="Cancer.gov" audience="Patient">Physical exam</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000322871" dictionary="Cancer.gov" audience="Patient">Neurological exam</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046157" dictionary="Cancer.gov" audience="Patient">Ultrasound exam</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045788" dictionary="Cancer.gov" audience="Patient">MRI</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046033" dictionary="Cancer.gov" audience="Patient">CT scan</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046140" dictionary="Cancer.gov" audience="Patient">PET scan</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_350">Other tests that may be needed include:</Para><ItemizedList id="_351" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000683250" dictionary="Cancer.gov" audience="Patient">Brain stem auditory evoked response (BAER) test</GlossaryTermRef>: A test that measures the brain's response to clicking sounds or certain tones to detect some types of hearing loss. </ListItem><ListItem><GlossaryTermRef href="CDR0000658018" dictionary="Cancer.gov" audience="Patient">Pulmonary function test</GlossaryTermRef> (PFT): A test to see how well the lungs are working. It measures how much air the lungs can hold and how quickly air moves into and out of the lungs. It also measures how much <GlossaryTermRef href="CDR0000538149" dictionary="Cancer.gov" audience="Patient">oxygen</GlossaryTermRef> is used and how much <GlossaryTermRef href="CDR0000538147" dictionary="Cancer.gov" audience="Patient">carbon dioxide</GlossaryTermRef> is given off during breathing. This is also called a lung function test.</ListItem><ListItem><GlossaryTermRef href="CDR0000304687" dictionary="Cancer.gov" audience="Patient">Chest x-ray</GlossaryTermRef>: An x-ray of the organs and bones inside the chest.  An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.</ListItem></ItemizedList><Para id="_317">The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called <GlossaryTermRef href="CDR0000044671" dictionary="Cancer.gov" audience="Patient">follow-up</GlossaryTermRef> tests or check-ups. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.</Para></SummarySection></SummarySection><SummarySection id="_318"><SectMetaData><SpecificDiagnosis ref="CDR0000039054">childhood Langerhans cell histiocytosis</SpecificDiagnosis></SectMetaData><Title>Treatment of Low-Risk LCH in Children</Title><Para id="_480">For information about the treatments listed below, see the <SummaryRef href="CDR0000597824#_63" url="/types/langerhans/patient/langerhans-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><SummarySection id="_98"><Title>Skin Lesions</Title><Para id="_99">Treatment of newly diagnosed childhood <GlossaryTermRef href="CDR0000471787" dictionary="Cancer.gov" audience="Patient">Langerhans cell histiocytosis</GlossaryTermRef> (LCH) skin <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> may include:</Para><ItemizedList id="_100" Style="bullet">
    <ListItem><GlossaryTermRef href="CDR0000045981" dictionary="Cancer.gov" audience="Patient">Observation</GlossaryTermRef>. Young children with skin-only LCH lesions  should be followed over a period of many years due to a risk of  <GlossaryTermRef href="CDR0000683346" dictionary="Cancer.gov" audience="Patient">diabetes insipidus</GlossaryTermRef>.</ListItem>
    </ItemizedList><Para id="_454">When severe <GlossaryTermRef href="CDR0000798604" dictionary="Cancer.gov" audience="Patient">rashes</GlossaryTermRef>, pain, <GlossaryTermRef href="CDR0000269469" dictionary="Cancer.gov" audience="Patient">ulceration</GlossaryTermRef>, or bleeding occur, treatment may include the following:</Para><ItemizedList id="_455" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">Steroid therapy</GlossaryTermRef>.</ListItem>
    <ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> given by mouth or <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef>.</ListItem>
   <ListItem>Chemotherapy applied to the skin.</ListItem><ListItem><GlossaryTermRef href="CDR0000045238" dictionary="Cancer.gov" audience="Patient">Photodynamic therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000439423" dictionary="Cancer.gov" audience="Patient">psoralen  and  ultraviolet A</GlossaryTermRef>    (PUVA) therapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000269473" dictionary="Cancer.gov" audience="Patient">UVB radiation</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef>.</ListItem></ItemizedList></SummarySection><SummarySection id="_102"><Title>Lesions in Bones or Other Low-Risk Organs</Title><Para id="_137">Treatment of newly diagnosed childhood <GlossaryTermRef href="CDR0000471787" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef> bone <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef>  in  the front, sides, or back of the <GlossaryTermRef href="CDR0000763008" dictionary="Cancer.gov" audience="Patient">skull</GlossaryTermRef>, or in any other single bone   may include:</Para><ItemizedList id="_104" Style="bullet">
    <ListItem><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef> (<GlossaryTermRef href="CDR0000046459" dictionary="Cancer.gov" audience="Patient">curettage</GlossaryTermRef>) with or without <GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">steroid therapy</GlossaryTermRef>.</ListItem>
    
   <ListItem><GlossaryTermRef href="CDR0000792092" dictionary="Cancer.gov" audience="Patient">Low-dose radiation therapy</GlossaryTermRef> for lesions that affect nearby <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organs</GlossaryTermRef>, or are painful and cannot be treated with other therapy. </ListItem></ItemizedList><Para id="_364">Treatment of newly diagnosed childhood LCH lesions in bones  around the ears or eyes is done to lower the risk of <GlossaryTermRef href="CDR0000683346" dictionary="Cancer.gov" audience="Patient">diabetes insipidus</GlossaryTermRef> and other long-term problems. Treatment may include:</Para><ItemizedList id="_391" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> and steroid therapy.</ListItem><ListItem>Surgery (curettage).</ListItem></ItemizedList><Para id="_319">Treatment of newly diagnosed childhood LCH lesions of the <GlossaryTermRef href="CDR0000415914" dictionary="Cancer.gov" audience="Patient">spine</GlossaryTermRef> or thigh bone may include:</Para><ItemizedList id="_320" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045981" dictionary="Cancer.gov" audience="Patient">Observation</GlossaryTermRef>.</ListItem><ListItem>Low-dose radiation therapy.</ListItem><ListItem>Chemotherapy, for lesions that spread from the spine into nearby <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef>.</ListItem><ListItem>Surgery to strengthen the weakened bone by bracing or fusing the bones together.</ListItem></ItemizedList><Para id="_365">Treatment of two or more bone lesions may include: </Para><ItemizedList id="_366" Style="bullet">
     <ListItem>Chemotherapy and steroid therapy.</ListItem></ItemizedList><Para id="_392">Treatment of two or more bone lesions combined with skin lesions,  <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph node</GlossaryTermRef> lesions, or diabetes insipidus may include:   </Para><ItemizedList id="_393" Style="bullet"><ListItem>Chemotherapy with or without steroid therapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000044817" dictionary="Cancer.gov" audience="Patient">Bisphosphonate</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef>.</ListItem></ItemizedList></SummarySection><SummarySection id="_479"><Title>CNS Lesions</Title><Para id="_428">Treatment of newly diagnosed childhood <GlossaryTermRef href="CDR0000471787" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef> <GlossaryTermRef href="CDR0000046481" dictionary="Cancer.gov" audience="Patient">central nervous system</GlossaryTermRef> (CNS) <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> may include:</Para><ItemizedList id="_429" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> with or without <GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">steroid therapy</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_456">Treatment of newly diagnosed LCH CNS <GlossaryTermRef href="CDR0000687218" dictionary="Cancer.gov" audience="Patient">neurodegenerative syndrome</GlossaryTermRef> may include:</Para><ItemizedList id="_457" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000750801" dictionary="Cancer.gov" audience="Patient">BRAF inhibitors</GlossaryTermRef> (<GlossaryTermRef href="CDR0000702051" dictionary="Cancer.gov" audience="Patient">vemurafenib</GlossaryTermRef> or <GlossaryTermRef href="CDR0000750069" dictionary="Cancer.gov" audience="Patient">dabrafenib</GlossaryTermRef>).</ListItem><ListItem>Chemotherapy.</ListItem><ListItem>Targeted therapy with a <GlossaryTermRef href="CDR0000046066" dictionary="Cancer.gov" audience="Patient">monoclonal antibody</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045525" dictionary="Cancer.gov" audience="Patient">rituximab</GlossaryTermRef>).</ListItem></ItemizedList></SummarySection><Para id="_TrialSearch_318_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_114"><Title>Treatment of High-Risk LCH in Children</Title><Para id="_4800">For information about the treatments listed below, see the <SummaryRef href="CDR0000597824#_63" url="/types/langerhans/patient/langerhans-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_115">Treatment of newly <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosed</GlossaryTermRef> childhood <GlossaryTermRef href="CDR0000513054" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef> multisystem disease <GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">lesions</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">spleen</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000045622" dictionary="Cancer.gov" audience="Patient">bone marrow</GlossaryTermRef> and another <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organ</GlossaryTermRef> or site may include:</Para><ItemizedList id="_324" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">steroid therapy</GlossaryTermRef>. Higher <GlossaryTermRef href="CDR0000044664" dictionary="Cancer.gov" audience="Patient">doses</GlossaryTermRef> of more than one chemotherapy drug and steroid therapy may be given to patients whose <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumors</GlossaryTermRef> do not <GlossaryTermRef href="CDR0000044085" dictionary="Cancer.gov" audience="Patient">respond</GlossaryTermRef> to initial chemotherapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> (<GlossaryTermRef href="CDR0000702051" dictionary="Cancer.gov" audience="Patient">vemurafenib</GlossaryTermRef>).</ListItem><ListItem>A liver <GlossaryTermRef href="CDR0000046631" dictionary="Cancer.gov" audience="Patient">transplant</GlossaryTermRef> for patients with severe liver damage.</ListItem><ListItem>A  clinical trial that tailors the patient's treatment based on features of the LCH at diagnosis and how it responds to treatment.</ListItem><ListItem>A clinical trial of chemotherapy and steroid therapy.</ListItem></ItemizedList></SummarySection><SummarySection id="_118"><Title>Treatment of Progressive, Refractory, or Recurrent       Childhood LCH in Children</Title><Para id="_4801">For information about the treatments listed below, see the <SummaryRef href="CDR0000597824#_63" url="/types/langerhans/patient/langerhans-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_478">Treatment of <GlossaryTermRef href="CDR0000045850" dictionary="Cancer.gov" audience="Patient">progressive</GlossaryTermRef>, <GlossaryTermRef href="CDR0000350245" dictionary="Cancer.gov" audience="Patient">refractory</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000045861" dictionary="Cancer.gov" audience="Patient">recurrent</GlossaryTermRef> low-risk LCH may include:</Para><ItemizedList id="_370" Style="bullet">
     <ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> with or without <GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">steroid therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000044817" dictionary="Cancer.gov" audience="Patient">Bisphosphonate</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_144">Treatment of progressive, refractory, or recurrent high-risk multisystem LCH may include:</Para><ItemizedList id="_469" Style="bullet"><ListItem>Chemotherapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> (<GlossaryTermRef href="CDR0000702051" dictionary="Cancer.gov" audience="Patient">vemurafenib</GlossaryTermRef>).</ListItem><ListItem><GlossaryTermRef href="CDR0000046695" dictionary="Cancer.gov" audience="Patient">Stem cell transplant</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_470">Treatments being studied for progressive, refractory, or recurrent childhood LCH include the following:</Para><ItemizedList id="_471" Style="bullet">
     <ListItem>A <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trial</GlossaryTermRef> that tailors the patient's treatment based on features of the LCH at <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosis</GlossaryTermRef> and how it <GlossaryTermRef href="CDR0000044085" dictionary="Cancer.gov" audience="Patient">responds</GlossaryTermRef> to treatment.</ListItem><ListItem>A clinical trial of targeted therapy (<GlossaryTermRef href="CDR0000750072" dictionary="Cancer.gov" audience="Patient">trametinib</GlossaryTermRef> and <GlossaryTermRef href="CDR0000750069" dictionary="Cancer.gov" audience="Patient">dabrafenib</GlossaryTermRef>).</ListItem></ItemizedList></SummarySection><SummarySection id="_236"><SectMetaData><SpecificDiagnosis ref="CDR0000641605">adult Langerhans cell histiocytosis</SpecificDiagnosis></SectMetaData><Title>Treatment of LCH in Adults</Title><SummarySection id="_432"><Para id="_394"><GlossaryTermRef href="CDR0000471787" dictionary="Cancer.gov" audience="Patient">Langerhans cell histiocytosis</GlossaryTermRef> (LCH)  in adults is a lot like  LCH in children and can form in the same <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organs</GlossaryTermRef> and systems as it does in children. These include the <GlossaryTermRef href="CDR0000468796" dictionary="Cancer.gov" audience="Patient">endocrine</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046481" dictionary="Cancer.gov" audience="Patient">central nervous systems</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">spleen</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045622" dictionary="Cancer.gov" audience="Patient">bone marrow</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046189" dictionary="Cancer.gov" audience="Patient">gastrointestinal tract</GlossaryTermRef>.  In adults, LCH is most commonly found in the <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lung</GlossaryTermRef> as a single-system disease. In some patients, other organs may be involved, including bone, skin, <GlossaryTermRef href="CDR0000046359" dictionary="Cancer.gov" audience="Patient">hypothalamus</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000046229" dictionary="Cancer.gov" audience="Patient">pituitary gland</GlossaryTermRef>.  LCH in the lung occurs more often in  young adults  who smoke. </Para><Para id="_395">As in children, the signs and <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> of LCH depend on where it is found in the body. See the <SummaryRef href="CDR0000597824#_289" url="/types/langerhans/patient/langerhans-treatment-pdq">General Information</SummaryRef>  section for the signs and symptoms of LCH.</Para><Para id="_396">Tests that examine the organs and body systems where LCH may occur are  used to detect (find) and <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef>  LCH. See the <SummaryRef href="CDR0000597824#_279" url="/types/langerhans/patient/langerhans-treatment-pdq">General Information</SummaryRef> section for tests and procedures used to diagnose LCH.</Para><Para id="_397">In adults, there is not a lot of information about what treatment works best.  Sometimes, information comes only from reports of the diagnosis, treatment, and <GlossaryTermRef href="CDR0000044671" dictionary="Cancer.gov" audience="Patient">follow-up</GlossaryTermRef> of one adult or a small group of  adults who were given the same type of treatment.</Para><Para id="_4812">Adult patients with LCH have higher rates of other cancers than do adults of the same age without LCH. These cancers may be found   before, at the same time, or after an LCH diagnosis, and occur more in patients who smoke.</Para><Para id="_481">For information about the treatments listed below, see the <SummaryRef href="CDR0000597824#_63" url="/types/langerhans/patient/langerhans-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para></SummarySection><SummarySection id="_379"><Title>Lung Lesions</Title><Para id="_380">Treatment for  <GlossaryTermRef href="CDR0000513054" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lung</GlossaryTermRef> in adults may include:</Para><ItemizedList id="_381" Style="bullet">
     <ListItem>Quitting smoking. Lung damage will get worse over time in patients who do not quit smoking. In patients who quit smoking, lung damage may get better or it may get worse over time.</ListItem><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef>.</ListItem><ListItem>Lung <GlossaryTermRef href="CDR0000046631" dictionary="Cancer.gov" audience="Patient">transplant</GlossaryTermRef> for patients with severe lung damage.</ListItem><ListItem><GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">Steroid therapy</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_421">Sometimes LCH of the lung will go away or not get worse even if it's not treated.</Para></SummarySection><SummarySection id="_398"><Title>Bone Lesions</Title><Para id="_399">Treatment for <GlossaryTermRef href="CDR0000513054" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef> that affects only  the bone in adults may include:</Para><ItemizedList id="_400" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef> with or without <GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">steroid therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">Radiation therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000044817" dictionary="Cancer.gov" audience="Patient">Bisphosphonate</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef>, for severe bone pain.</ListItem><ListItem><GlossaryTermRef href="CDR0000489392" dictionary="Cancer.gov" audience="Patient">Anti-inflammatory drugs</GlossaryTermRef> (<GlossaryTermRef href="CDR0000410212" dictionary="Cancer.gov" audience="Patient">pioglitazone</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045083" dictionary="Cancer.gov" audience="Patient">rofecoxib</GlossaryTermRef>) with chemotherapy.</ListItem></ItemizedList></SummarySection><SummarySection id="_401"><Title>Skin Lesions</Title><Para id="_402">Treatment for <GlossaryTermRef href="CDR0000513054" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef> that affects only the skin in adults may include:</Para><ItemizedList id="_403" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef>.</ListItem>
   <ListItem><GlossaryTermRef href="CDR0000045111" dictionary="Cancer.gov" audience="Patient">Steroid</GlossaryTermRef> or other <GlossaryTermRef href="CDR0000651195" dictionary="Cancer.gov" audience="Patient">drug therapy</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045414" dictionary="Cancer.gov" audience="Patient">tacrolimus</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045080" dictionary="Cancer.gov" audience="Patient">imiquimod</GlossaryTermRef>) applied or <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injected</GlossaryTermRef> into the skin.</ListItem><ListItem><GlossaryTermRef href="CDR0000045238" dictionary="Cancer.gov" audience="Patient">Photodynamic therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000439423" dictionary="Cancer.gov" audience="Patient">psoralen  and  ultraviolet A</GlossaryTermRef>  (PUVA) radiation.</ListItem><ListItem><GlossaryTermRef href="CDR0000269473" dictionary="Cancer.gov" audience="Patient">UVB radiation</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">immunotherapy</GlossaryTermRef> given by mouth, such as <GlossaryTermRef href="CDR0000045393" dictionary="Cancer.gov" audience="Patient">methotrexate</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045458" dictionary="Cancer.gov" audience="Patient">thalidomide</GlossaryTermRef>,  or <GlossaryTermRef href="CDR0000045308" dictionary="Cancer.gov" audience="Patient">hydroxyurea</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_430">Treatment for LCH that affects the skin and other body systems in adults may include:</Para><ItemizedList id="_431" Style="bullet"><ListItem>Chemotherapy.</ListItem></ItemizedList></SummarySection><SummarySection id="_404"><Title>Single-System and Multisystem Disease</Title><Para id="_405">Treatment of single-system and multisystem disease in adults that does not affect the <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lung</GlossaryTermRef>, bone, or skin may include:</Para><ItemizedList id="_406" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef>. </ListItem><ListItem><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">Radiation therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> (<GlossaryTermRef href="CDR0000702051" dictionary="Cancer.gov" audience="Patient">vemurafenib</GlossaryTermRef>).</ListItem></ItemizedList></SummarySection><Para id="_407">For more  about <GlossaryTermRef href="CDR0000513054" dictionary="Cancer.gov" audience="Patient">LCH</GlossaryTermRef> trials for adults, see the <ExternalRef xref="http://www.histiocytesociety.org/">Histiocyte Society</ExternalRef> website.</Para><Para id="_TrialSearch_236_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_460"><SectMetaData><SectionType>Resources</SectionType></SectMetaData><Title>To Learn More About Langerhans Cell Histiocytosis</Title><Para id="_461">For more  from the <GlossaryTermRef href="CDR0000044266" dictionary="Cancer.gov" audience="Patient">National Cancer Institute</GlossaryTermRef> 
        about Langerhans cell histiocytosis treatment, see the following:</Para><ItemizedList id="_462" Style="bullet">
   <ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/diagnosis-staging/ct-scans-fact-sheet">Computed Tomography (CT) Scans and Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy">Photodynamic Therapy for Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy">Immunotherapy to Treat Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant">Stem Cell Transplants in Cancer Treatment</ExternalRef></ListItem>
   
   
  </ItemizedList><Para id="_460_md_44">For more childhood cancer information and other general cancer resources, visit:</Para><ItemizedList id="_460_md_45" Style="bullet"><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer">About Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/types/childhood-cancers">Childhood Cancers</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.curesearch.org/">CureSearch for Children's Cancer</ExternalRef>
</ListItem><ListItem><SummaryRef href="CDR0000373791" url="/types/childhood-cancers/late-effects-pdq">Late Effects of Treatment for Childhood Cancer</SummaryRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/types/aya">Adolescents and Young Adults with Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/publications/patient-education/guide-for-parents">Children with Cancer: A Guide for Parents</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet">Cancer in Children and Adolescents</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/diagnosis-staging/staging">Cancer Staging</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/coping">Coping with Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/coping/questions">Questions to Ask Your Doctor about Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://cancercontrol.cancer.gov/ocs/resources/survivors.html">For Survivors, Caregivers, and Advocates</ExternalRef></ListItem></ItemizedList></SummarySection><SummarySection id="_AboutThis_1"><Title>About This PDQ Summary</Title><SummarySection id="_AboutThis_2"><Title>About PDQ</Title><Para id="_AboutThis_3">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <ExternalRef xref="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</ExternalRef>.</Para><Para id="_AboutThis_4">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government’s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</Para></SummarySection><SummarySection id="_AboutThis_5"><Title>Purpose of This Summary</Title><Para id="_AboutThis_6">This PDQ cancer information summary has current information about the treatment of childhood and adult Langerhans cell histiocytosis.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para></SummarySection><SummarySection id="_AboutThis_7"><Title>Reviewers and Updates</Title><Para id="_AboutThis_8">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
</Para><Para id="_AboutThis_9">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <ExternalRef xref="https://www.cancer.gov/publications/pdq/editorial-boards/pediatric-treatment">PDQ Pediatric Treatment Editorial Board</ExternalRef>.
</Para></SummarySection><SummarySection id="_AboutThis_10"><Title>Clinical Trial Information</Title><Para id="_AboutThis_11">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
</Para><Para id="_AboutThis_12">Clinical trials can be found online at <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI's website</ExternalRef>. For more information, call the <ExternalRef xref="https://www.cancer.gov/contact/contact-center">Cancer Information Service</ExternalRef> (CIS), NCI's contact center, at 1-800-4-CANCER (1-800-422-6237).
</Para></SummarySection><SummarySection id="_AboutThis_13"><Title>Permission to Use This Summary</Title><Para id="_AboutThis_14">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as “NCI’s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].”
</Para><Para id="_AboutThis_15">The best way to cite this PDQ summary is:</Para><Para id="_AboutThis_21">PDQ® Pediatric Treatment Editorial Board. PDQ Langerhans Cell Histiocytosis Treatment. Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <ExternalRef xref="https://www.cancer.gov/types/langerhans/patient/langerhans-treatment-pdq">https://www.cancer.gov/types/langerhans/patient/langerhans-treatment-pdq</ExternalRef>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389196]</Para><Para id="_AboutThis_16">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <ExternalRef xref="https://visualsonline.cancer.gov/">Visuals Online</ExternalRef>. Visuals Online is a collection of more than 3,000 scientific images.
</Para></SummarySection><SummarySection id="_AboutThis_17"><Title>Disclaimer</Title><Para id="_AboutThis_18">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <ExternalRef xref="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</ExternalRef> page.</Para></SummarySection><SummarySection id="_AboutThis_19"><Title>Contact Us</Title><Para id="_AboutThis_20">More information about contacting us or receiving help with the Cancer.gov website can be found on our <ExternalRef xref="https://www.cancer.gov/contact">Contact Us for Help</ExternalRef> page. Questions can also be submitted to Cancer.gov through the website’s <ExternalRef xref="https://www.cancer.gov/contact/email-us">E-mail Us</ExternalRef>.</Para></SummarySection></SummarySection><PatientVersionOf ref="CDR0000600550"/><DateFirstPublished>2010-07-16</DateFirstPublished><DateLastModified>2024-06-06</DateLastModified></Summary>
